| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/30/2013 | US20130137754 Tumor therapy with replication competent sindbis viral vectors |
| 05/30/2013 | US20130136789 Agent for treating renal fibrosis |
| 05/30/2013 | US20130136762 Modified surface antigen |
| 05/30/2013 | US20130136726 Method for detection of predisposition to atherosclerosis, coronary heart disease and related conditions |
| 05/30/2013 | CA2856137A1 Virus vectors for highly efficient transgene delivery |
| 05/29/2013 | EP2596807A1 Complement binding aptamers and anti-C5 agents useful in the treatment of ocular disorders |
| 05/29/2013 | EP2596806A1 Method for prevention of colectomy |
| 05/29/2013 | EP2596101A1 Genome editing using targeting endonucleases and single-stranded nucleic acids |
| 05/29/2013 | EP2595644A1 Amyloid-beta clearance |
| 05/29/2013 | EP2595604A2 METHOD OF CONTROLLING INITIAL DRUG RELEASE OF siRNA FROM SUSTAINED-RELEASE IMPLANTS |
| 05/29/2013 | EP2595602A2 SUSTAINED RELEASE siRNA FOR OCULAR DRUG DELIVERY |
| 05/29/2013 | CN1956738B Antibodies to MAdCAM |
| 05/29/2013 | CN1582165B Antibodies to CD40 |
| 05/29/2013 | CN103124787A Method for producing virus vector |
| 05/29/2013 | CN103122360A Chimeric adenoviral vectors |
| 05/29/2013 | CN103122353A Porcine O-type foot-and-mouth disease virus recombinant baculovirus as well as preparation method and application thereof |
| 05/29/2013 | CN103122352A Porcine circovirus II-type recombinant baculovirus as well as preparation method and application thereof |
| 05/29/2013 | CN103121959A Compound, nucleic acid compound molecules and nucleic acid complex as well as preparation methods and application thereof |
| 05/29/2013 | CN102399284B Fox growth hormone releasing hormone cDNA and its application |
| 05/29/2013 | CN102399283B Mink growth hormone releasing hormone cDNA and application thereof |
| 05/29/2013 | CN102370987B Injection liposome entrapping antineoplastic pharmaceutical composition |
| 05/29/2013 | CN102161991B Single-strand multi-target interfering nucleic acid molecule and application thereof |
| 05/28/2013 | US8450470 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments |
| 05/28/2013 | US8450468 Nucleic acid inhibitors of glutamate receptors |
| 05/28/2013 | US8450290 Methods for treating androgen receptor dependent disorders including cancers |
| 05/28/2013 | US8450289 Compositions comprising a parvovirus VP1-variant and a parvovirus NS1 protein for induction of cytolysis |
| 05/28/2013 | US8450288 For introduction of a disc prosthesis or implant; involves providing substance(s) beneficial to the intervertebral disc through a cannulated element |
| 05/28/2013 | US8450112 Engineering and delivery of therapeutic compositions of freshly isolated cells |
| 05/28/2013 | US8450097 Protein-proteophore complexes |
| 05/28/2013 | US8450087 Use of triplex structure DNA in transferring nucleotide sequences |
| 05/28/2013 | US8449875 Targeting pseudotyped retroviral vectors |
| 05/28/2013 | CA2644552C Peptide lipid-containing carrier and method for introducing compound into cells using same |
| 05/28/2013 | CA2592891C Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation |
| 05/28/2013 | CA2517258C Recombinant measles virus comprising dengue or west nile virus polynucleotides, and their use in vaccinal and therapeutic applications |
| 05/28/2013 | CA2506581C Novel 2',5'-oligoadenylic acid analogues |
| 05/28/2013 | CA2476773C Monoclonal antibodies against extracellular loops of c5ar |
| 05/28/2013 | CA2459769C Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses |
| 05/28/2013 | CA2453301C Synthetic double-stranded oligonucleotides for specific inhibition of gene expression |
| 05/28/2013 | CA2448620C Vaccination against the feline immunodeficiency virus |
| 05/28/2013 | CA2427902C Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 05/28/2013 | CA2406180C Viruses comprising mutant ion channel protein |
| 05/28/2013 | CA2323210C Enhancement of intracellular delivery and tissue targeting of drugs and genes |
| 05/28/2013 | CA2285692C Enhancement of immune response using targeting molecules |
| 05/23/2013 | WO2013075008A1 Aav dual vector systems for gene therapy |
| 05/23/2013 | WO2013074820A1 Immunogenic tumor associated stromal cell antigen peptides and methods of their use |
| 05/23/2013 | WO2013074794A1 Latent human immunodeficiency virus reactivation |
| 05/23/2013 | WO2013073775A1 Novel method for preparing metabolites of atorvastatin using bacterial cytochrome p450 and composition therefor |
| 05/23/2013 | WO2013073602A1 Nucleic acid fragment binding to target protein |
| 05/23/2013 | WO2013073480A1 Cationic lipid having improved intracellular kinetics |
| 05/23/2013 | WO2013049531A3 Multilayer magnetic micelle compositions and methods for their use |
| 05/23/2013 | WO2013049026A3 Neurabin scaffolding of the adenosine receptor and rgs4 regulates anti-seizure effect of endogenous adenosine |
| 05/23/2013 | WO2013015586A3 Vaccine composition for preventing and treating colibacillosis and salmonellosis in poultry, containing a salmonella strain expressing virulence factors of pathogenic escherichia coli of poultry |
| 05/23/2013 | WO2012165854A9 Long interfering dsrna simultaneously inducing an immune reaction and the inhibition of the expression of target genes |
| 05/23/2013 | US20130133092 Sequence-specific dna recombination in eukaryotic cells |
| 05/23/2013 | US20130131312 Peptide conjugated, inosine-substituted antisense oligomer compound and method |
| 05/23/2013 | US20130131148 Micro-rna for cancer diagnosis, prognosis and therapy |
| 05/23/2013 | US20130130986 Cancer treatment with recombinant vector |
| 05/23/2013 | US20130130375 Use of fibroblast growth factor for lineage priming and differentiation of pluripotent stem cells |
| 05/23/2013 | US20130130370 MicroRNA and Methods for Inhibiting Same |
| 05/23/2013 | US20130129719 Her2 nucleic acid aptamers |
| 05/23/2013 | US20130129717 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/23/2013 | US20130129702 Materials and methods for prevention and treatment of rna viral diseases |
| 05/23/2013 | US20130129696 Human Stem Cell Materials and Methods |
| 05/23/2013 | CA2856288A1 Nucleic acid fragment binding to target protein |
| 05/22/2013 | EP2594644A1 Method for preparing novel hipsc by means of mirna introduction |
| 05/22/2013 | EP2594643A1 Method for producing novel hipsc by means of sirna introduction |
| 05/22/2013 | EP2594642A1 Induction of exon skipping in eukaryotic cells |
| 05/22/2013 | EP2594641A1 Induction of exon skipping in eukaryotic cells |
| 05/22/2013 | EP2594640A1 Induction of exon skipping in eukaryotic cells |
| 05/22/2013 | EP2594592A1 (nucleic acid)-polysaccharide complex |
| 05/22/2013 | EP2594275A1 Prophylactic or therapeutic agent for diabetes |
| 05/22/2013 | EP2594274A1 Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof |
| 05/22/2013 | EP2593547A2 Treatment of discs large homolog (dlg) related diseases by inhibition of natural antisense transcript to dlg |
| 05/22/2013 | EP2047867B1 ACE2 activation for treatment of heart, lung and kidney disease and hypertension |
| 05/22/2013 | CN1384759B Single-stranded oligodeoxynucleotide mutation vectors |
| 05/22/2013 | CN103119166A Prophylactic or therapeutic agent for fibrosis |
| 05/22/2013 | CN103118709A Ectodomains of influenza matrix 2 protein, expression system, and uses thereof |
| 05/22/2013 | CN103118693A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl tRNA synthetases |
| 05/22/2013 | CN103114094A Amphioxus endonuclear protein, and expression gene and application thereof |
| 05/22/2013 | CN103114087A RNA(Ribonucleic Acid)and application thereof in diseases of cardiovascular system |
| 05/22/2013 | CN103113472A Fusion peptide with myocardial preservation function as well as preparation method and application thereof |
| 05/22/2013 | CN103113470A Genetically engineered lymphocyte targeting Human EGFR (Epidermal Growth Factor Receptor), preparation method and application of genetically engineered lymphocyte |
| 05/22/2013 | CN103110960A Application of esophagus cancer related gene-4 |
| 05/22/2013 | CN103110959A Application of diacylglycerol kinase alpha gene-chitosan nanoparticle in preparing medicine for treating allergic asthma |
| 05/22/2013 | CN103110958A Application of TT1 gene in preparation of medicines for treating tumors |
| 05/22/2013 | CN103110955A Nano-drug carrier, reduction response nano-drug granules, nano-drug granular preparation and preparation method thereof |
| 05/22/2013 | CN103110954A Cholesterol-modified biodegradable polycation carrier as well as preparation method and application thereof |
| 05/22/2013 | CN103110932A Novel application of HIP-55 (hematopoietic progenitor kinase 1 [HPK1]-interacting protein of 55kDa) |
| 05/22/2013 | CN102579357B Magnet composite drug-carrying microspheres and preparation method thereof |
| 05/22/2013 | CN102417912B Molecular design of porcine parvovirus-like particle B cell epitope insertion site |
| 05/22/2013 | CN102382187B FBXL15 protein fragment, coding gene thereof, and application of FBXL15 protein fragment and coding gene |
| 05/22/2013 | CN101778643B Method and apparatus for the delivery of polynucleotide vaccines to mammalian skin |
| 05/22/2013 | CN101766818B Polysaccharide gold-magnetic composite particle medicine carrier and preparation method thereof |
| 05/21/2013 | US8445665 Therapeutic compositions |
| 05/21/2013 | US8445663 Compositions and methods that enhance an immune response |
| 05/21/2013 | US8445660 Chimeric vaccines |
| 05/21/2013 | US8445455 Stress-responsive induction of a therapeutic agent and methods of use |
| 05/21/2013 | US8445454 Use on minicircle vectors for cardiac gene therapy |
| 05/21/2013 | US8445453 CCR ligands for stem cell homing |
| 05/21/2013 | US8445268 Her-2/neu DNA vaccine having anti-cancer activity |